Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for Down syndrome
Open Access
- 6 August 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 30 (10), 2419-2426
- https://doi.org/10.1093/humrep/dev192
Abstract
How does a national prenatal screening program for Down syndrome (DS) perform in detecting sex chromosome abnormalities (SCAs)—Turner syndrome (TS), Klinefelter syndrome, 47,XXX and 47,XYY syndromes. The SCA detection rate resulting from DS screening was below 50% for all four groups of SCAs. The detection rates of SCAs are higher in countries with DS screening. TS is associated with greater nuchal translucency (NT) and lower pregnancy-associated plasma protein-A (PAPP-A). However, specific detection rates of SCAs using prenatal DS screening have not been determined. No clear trend in PAPP-A, free beta human chorionic gonadotropin (β-hCG) and NT has been found in the remaining SCAs. Several lines of inquiry suggest that it would be advantageous for individuals with SCA to be detected early in life, leading to prevention or treatment of accompanying conditions. There is limited information about pre- and perinatal status that distinguishes SCA embryogenesis from normal fetal development. A register-based case–control study from the Danish Central Cytogenetic Register (DCCR), cross-linked with the Danish Fetal Medicine Database (DFMD), was performed from 2008 to 2012. Groups of SCAs were compared with DS and then matched with non-SCA controls to assess differences between these groups in prenatal markers and birth outcomes. We included cases with prenatal and post-natal SCA karyotypes (n = 213), DS (n = 802) and 168 056 controls. We screened 275 037 individuals examined prenatally. We retrieved information regarding maternal age, NT, β-hCG and PAPP-A, as well as details regarding maternal and newborn characteristics. The DS screening procedure detected 87 per 100 000 TS (42% of expected), 19 per 100 000 Klinefelter syndrome (13% of expected), 16 per 100 000 47,XXX (16% of cases) and 5 per 100 000 47,XYY (5% of expected) SCAs, with an overall detection rate of 27%. Compared with controls, all four SCA groups showed significantly higher NT and lower PAPP-A compared with controls (all P < 0.01) and similar to DS. The legal abortion rate was high for all four syndromes (47,XXX: 24%; 47,XYY: 29%; Klinefelter syndrome: 48%, TS: 84%). For SCA fetuses carried to term, only TS fetuses had consistently lower birthweights and placenta weights than non-SCA controls (both P = 0.0001). A few SCA cases localized in DCCR could not be found in DFMD (n = 16). Controls were matched on sex of the fetus of cases, meaning that all electively aborted fetuses (before week 12) were excluded, possibly reducing the diversity in the control group. We were not able to localize all diagnosed cases of SCA and DS in DFMD. Although these cases were present in DCCR, we were not able to account for the discrepancy. In addition, we suspect that several SCA children have not been diagnosed yet and future post-natal diagnosis of these cases would reduce the diagnostic yield reported here even further. The prenatal detection rate is below 50% for all SCAs. The approach used for detecting DS cannot be extended to also include SCAs. In addition, all SCAs have low PAPP-A and increased NT, thus probably reflecting an abnormal embryogenesis. Growth retardation of TS fetuses is if anything more pronounced than previously reported, both when evaluating fetus and placenta. This study received support from Aarhus University and the Novo Nordisk Foundation. The authors have no competing interests that may be relevant to the study.Keywords
Funding Information
- Department of Clinical Medicine, Aarhus University Hospital
- Novo Nordisk Foundation
This publication has 41 references indexed in Scilit:
- Is Testosterone Replacement Therapy in Males with Hypogonadism Cost-Effective? An Analysis in SwedenThe Journal of Sexual Medicine, 2014
- Detection of increased gene copy number in DNA from dried blood spot samples allows efficient screening for Klinefelter syndromeActa Paediatrica, 2012
- hCG, the wonder of today's scienceReproductive Biology and Endocrinology, 2012
- Sex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancyEuropean Journal of Human Genetics, 2010
- Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort studyBMJ, 2008
- Abnormal meiotic recombination in infertile men and its association with sperm aneuploidyHuman Molecular Genetics, 2007
- Care of Girls and Women with Turner Syndrome: A Guideline of the Turner Syndrome Study GroupJournal of Clinical Endocrinology & Metabolism, 2007
- Prospective first-trimester screening for trisomy 21 in 30,564 pregnanciesAmerican Journal of Obstetrics and Gynecology, 2005
- Prenatal and Postnatal Prevalence of Klinefelter Syndrome: A National Registry StudyJournal of Clinical Endocrinology & Metabolism, 2003
- Turner's syndrome in Italy: familial characteristics, neonatal data, standards for birth weight and for height and weight from infancy to adulthoodActa Paediatrica, 1994